# Inpatient vs outpatient treatment management with teclistamab in relapsed and refractory multiple myeloma: A cost and healthcare resource utilization analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/inpatient-vs-outpatient-treatment-management-with-teclistamab-in-relapsed-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Niels W.C.J. van de Donk,Ruth Wester,Inger S. Nijhof,Claire Albrecht,Raúl Balsera Moraño,Cristina Entrala,Kirsten van Nimwegen |
| Citations | 1 |
| DOI | 10.1182/blood-2025-7936 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ashpublications.org/blood/article-pdf/146/Supplement 1/7936/2451559/blood-10683-main.pdf |
| OpenAlex ID | https://openalex.org/W4417016644 |
| Type | conference-abstract |
| Year | 2025 |

## Paper authors

- [Kirsten van Nimwegen](https://scholariq.org/researchers/kirsten-van-nimwegen/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.